Search alternatives:
significant compared » significant component (Expand Search), significantly impaired (Expand Search), significant impact (Expand Search)
compared disease » complex disease (Expand Search), pompe disease (Expand Search), compared risks (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
Showing 61 - 80 results of 99,444 for search '(( significant compared disease ) OR ( significant ((changes decrease) OR (largest decrease)) ))', query time: 1.71s Refine Results
  1. 61
    Multifidus, erector spinae, and psoas major muscle parameters and analysis of variance results.

    Multifidus, erector spinae, and psoas major muscle parameters and analysis of variance results. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 62
    Comparison of multifidus rmCSA among the three groups.

    Comparison of multifidus rmCSA among the three groups. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 63
    MRI of the lumbar spine in axial view at L4–L5 lumbar level.

    MRI of the lumbar spine in axial view at L4–L5 lumbar level. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 64
    Comparison of erector spinae rmCSA among the three groups.

    Comparison of erector spinae rmCSA among the three groups. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 65
    Study sample characteristics by groups.

    Study sample characteristics by groups. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 66
    Comparison of multifidus MFI index among the three groups.

    Comparison of multifidus MFI index among the three groups. by Faranak Mahmoudi Alami (18309967)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 67
    Significant lipids by category-Tiers 1, 2, and 3.

    Significant lipids by category-Tiers 1, 2, and 3. by Keenan Elliott (17181211)

    Published 2023
    Save to List
    Saved in:
  8. 68
    Changes in sleep habits and sleep-related symptoms.

    Changes in sleep habits and sleep-related symptoms. by Hea Ree Park (10769827)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss.

    Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss. by Thomas R. Shearer (9761486)

    Published 2023
    Save to List
    Saved in:
  10. 70
    Summary of significant single-arm time effect.

    Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

    Published 2024
    Save to List
    Saved in:
  11. 71
    Change of proportions between phases and statistical test results (corresponding to Figs 2–4).

    Change of proportions between phases and statistical test results (corresponding to Figs 2–4). by Lan Li (73597)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 72
    Species richness decreases significantly with increasing percent disturbance.

    Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

    Published 2019
    Save to List
    Saved in:
  13. 73
    Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically significant (<i>p</i> < 0.05) and non-significant (p > 0.05) values.

    Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically si... by Oswaldo Maillard (20660661)

    Published 2025
    Save to List
    Saved in:
  14. 74
    Impact of interventions on attendances and disease spectra based on segmented regression analysis.

    Impact of interventions on attendances and disease spectra based on segmented regression analysis. by Weiqin Liu (8489124)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 75
    Baseline rates, trends, and changes in cesarean section rates in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2 years after policy change.

    Baseline rates, trends, and changes in cesarean section rates in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2... by Ingvild Hersoug Nedberg (11384048)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 76
    Changes in inflammatory cytokine levels compared with baseline values in all patients over time.

    Changes in inflammatory cytokine levels compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Poisson multiple regression models of the impact of the coronavirus disease pandemic on the hospitalization rate for cancer in Brazil according to subgroups by age group, sex, and region of Brazil.

    Poisson multiple regression models of the impact of the coronavirus disease pandemic on the hospitalization rate for cancer in Brazil according to subgroups by age group, sex, and... by Rafael Alves Guimarães (4526788)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 78
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Mortality risk in patients with CVD and hypertension—Advanced disease.

    Mortality risk in patients with CVD and hypertension—Advanced disease. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 80
    Metabologenomics.

    Metabologenomics. by Francesco Favero (236209)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: